"Since 1970, Fox Valley Surgical Associates has been dedicated to providing top-notch care throughout Northeast Wisconsin. With many of our surgeons and physicians fellowship trained in their specialties-endocrinology and breast care to vascular, oncologic, colorectal and general surgery-FVSA has developed a reputation of unparalleled excellence in our community for the last 50 years."

During the past decade, Fox Valley Surgical Associates Limited conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fox Valley Surgical Associates Limited" #1 sponsor was "National Cancer Institute (NCI)" with 5 trials, followed by "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored, "Ethicon Endo-Surgery" with 1 trials sponsored and "Johns Hopkins University" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fox Valley Surgical Associates Limited" #1 collaborator was "National Cancer Institute (NCI)" with 5 trials as a collaborator, "American College of Radiology Imaging Network" with 1 trials as a collaborator, "American College of Surgeons" with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator and "Cancer and Leukemia Group B" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Fox Valley Surgical Associates Limited" are "Stage II Breast Cancer" (3 trials), "Stage IB Breast Cancer" (2 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (2 trials), "Stage II Lung Non-Small Cell Cancer AJCC v7" (2 trials) and "Stage IIA Breast Cancer AJCC v6 and v7" (2 trials). Many other conditions were trialed in "Fox Valley Surgical Associates Limited" in a lesser frequency.

Most popular intervention types in "Fox Valley Surgical Associates Limited" are "Other" (6 trials), "Drug" (5 trials), "Procedure" (4 trials), "Radiation" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (5 trials), "Clinical Observation" (3 trials), "Carboplatin" (2 trials), "Crizotinib" (2 trials) and "Paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Fox Valley Surgical Associates Limited" are 8 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Fox Valley Surgical Associates Limited". undefined are not yet recruiting, 3 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in Fox Valley Surgical Associates Limited, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fox Valley Surgical Associates Limited, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".